Evidence map›Paper›PMID 40896270›Full record

ReviewFrontiers in chemistry2025

Organic functionality in responsive paramagnetic nanostructures.

Anna M Duncan, Connor M Ellis, James P Smith, Lillian Leutloff, Matthew J Langton, Jason J Davis

Abstract readReview
In one paragraph

Review in Frontiers in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna M DuncanDepartment of Chemistry, University of Oxford, Oxford, United Kingdom.
Connor M EllisDepartment of Chemistry, University of Oxford, Oxford, United Kingdom.
James P SmithDepartment of Chemistry, University of Oxford, Oxford, United Kingdom.
Lillian LeutloffDepartment of Chemistry, University of Oxford, Oxford, United Kingdom.
Matthew J LangtonDepartment of Chemistry, University of Oxford, Oxford, United Kingdom.
Jason J DavisDepartment of Chemistry, University of Oxford, Oxford, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic resonance imaging (MRI) has become an invaluable tool for diagnosing and monitoring a range of medical conditions, including cancer and cardiovascular disease, owing, in large part, to its high spatial resolution. Despite this, MRI suffers from an inherent low sensitivity, a drawback that can be mitigated through the use of exogenous contrast agents. Although molecular paramagnetic contrast agents are most commonly used, they suffer from significant limitations, including short circulation times, inadequate sensitivity, moderate (or no) tissue specificity, and potential toxicity. Recent advancements in nanomaterials research have paved the way for the development of paramagnetic nanoplatforms offering a promising alternative to these traditional chelates. Responsive contrast agents have gained attention due to their ability to generate local contrast in areas of particular interest, enabling the potential for disease-specific reporting where environmental factors including pH, ion concentration and biomolecule activity deviate from the norm. In addition to this, the generation of local or locality-specific contrast can help to overcome the intrinsic nonspecific nature of traditional contrast agents allowing for overall better treatment options. Purely organic nanoparticles, including those which are micellar, liposomal or dendritic and inorganic-polymer hybrids, can support step changes in MRI signal generation and its diagnostic potency by leveraging the specific and responsive characteristics of the organic components. This review seeks to illustrate how the integration of organic chemistry into magnetic nanostructures can enable responsive high-contrast generation.

Indexed as

MRInanoparticlesorganicpolymersresponsive

Identifiers

PMID40896270
PMCPMC12390991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.